Literature DB >> 12021197

The lethal form of Cushing's in 7B2 null mice is caused by multiple metabolic and hormonal abnormalities.

Miroslav S Sarac1, Arthur W Zieske, Iris Lindberg.   

Abstract

The neuroendocrine-specific protein 7B2, which serves as a molecular escort for proPC2 in the secretory pathway, promotes the production of enzymatically active PC2 and may have non-PC2 related endocrine roles. Mice null for 7B2 exhibit a lethal phenotype with a complex Cushing's-like pathology, which develops from intermediate lobe ACTH hypersecretion as a consequences of interruption of PC2-mediated peptide processing as well as undefined consequences of the loss of 7B2. In this study we investigated the endocrine and metabolic alterations of 7B2 null mice from pathological and biochemical points of view. Our results show that 7B2 nulls exhibit a multisystem disorder that includes severe pathoanatomical and histopathologic alterations of vital organs, including the heart and spleen but most notably the liver, in which massive steatosis and necrosis are observed. Metabolic derangements in glucose metabolism result in glycogen and fat deposition in liver under conditions of chronic hypoglycemia. Liver failure is also likely to contribute to abnormalities in blood coagulation and blood chemistry, such as lactic acidosis. A hypoglycemic crisis coupled with respiratory distress and intensive internal thrombosis most likely results in rapid deterioration and death of the 7B2 null.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021197     DOI: 10.1210/endo.143.6.8808

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  Dynamic modulation of prohormone convertase 2 (PC2)-mediated precursor processing by 7B2 protein: preferential effect on glucagon synthesis.

Authors:  Michael Helwig; Sang-Nam Lee; Jae Ryoung Hwang; Akihiko Ozawa; Juan F Medrano; Iris Lindberg
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

Review 2.  The extended granin family: structure, function, and biomedical implications.

Authors:  Alessandro Bartolomucci; Roberta Possenti; Sushil K Mahata; Reiner Fischer-Colbrie; Y Peng Loh; Stephen R J Salton
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

Review 3.  Gene therapy for pituitary tumors.

Authors:  Adriana Seilicovich; Daniel Pisera; Sandra A Sciascia; Marianela Candolfi; Mariana Puntel; Weidong Xiong; Gabriela Jaita; Maria G Castro
Journal:  Curr Gene Ther       Date:  2005-12       Impact factor: 4.391

4.  Strain-specific steroidal control of pituitary function.

Authors:  Sang-Nam Lee; Bonnie Peng; Roxane Desjardins; John E Pintar; Robert Day; Iris Lindberg
Journal:  J Endocrinol       Date:  2007-03       Impact factor: 4.286

Review 5.  The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia.

Authors:  Steven A Feldman; Lee E Eiden
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

6.  Pax6 regulates the proglucagon processing enzyme PC2 and its chaperone 7B2.

Authors:  Liora S Katz; Yvan Gosmain; Eric Marthinet; Jacques Philippe
Journal:  Mol Cell Biol       Date:  2009-02-17       Impact factor: 4.272

7.  Interaction of insulin with prokinetic drugs in STZ-induced diabetic mice.

Authors:  Mohamed A Fouad Shalaby; Hekma A Abd El Latif; Mostafa E El Sayed
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-05-06

Review 8.  Mouse Models of Human Proprotein Convertase Insufficiency.

Authors:  Manita Shakya; Iris Lindberg
Journal:  Endocr Rev       Date:  2021-05-25       Impact factor: 19.871

9.  Secretory granule neuroendocrine protein 1 (SGNE1) genetic variation and glucose intolerance in severe childhood and adult obesity.

Authors:  Nabila Bouatia-Naji; Vincent Vatin; Cécile Lecoeur; Barbara Heude; Christine Proença; Jacques Veslot; Béatrice Jouret; Jean Tichet; Guillaume Charpentier; Michel Marre; Beverley Balkau; Philippe Froguel; David Meyre
Journal:  BMC Med Genet       Date:  2007-07-07       Impact factor: 2.103

10.  Pituitary protein 7B2 plasma levels in patients with liver disease: Comparisons with other hormones and neuropeptides.

Authors:  Maria S Venetikou; Luke Meleagros; Mohhammad A Ghatei; Stephen R Bloom
Journal:  Oncol Lett       Date:  2013-06-07       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.